I2-Imidazoline receptors and monoamine oxidase B enzyme sites in human brain:: covariation with age

被引:9
作者
Ballesteros, J [1 ]
Maeztu, AI
Callado, LF
Gutiérrez, M
García-Sevilla, JA
Meana, JJ
机构
[1] Univ Basque Country, Dept Neurosci, E-48940 Leioa, Bizkaia, Spain
[2] Maria Josefa Recio Fdn, Inst Psychiat Res, Bilbao 48010, Spain
[3] Univ Basque Country, Dept Pharmacol, E-48940 Leioa, Bizkaia, Spain
[4] Hosp Santiago, Dept Psychiat, Vitoria 01004, Spain
[5] Univ Balearic Isl, Dept Biol, CSIC, Associate Unit,Inst Cajal,Lab Neuropharmacol, E-07071 Palma de Mallorca, Spain
关键词
I-2-imidazoline receptors; monoamine oxidase B; human brain; aging; idazoxan; lazabemide;
D O I
10.1016/S0304-3940(00)01218-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
An association between monoamino oxidase B enzyme (MAO-B) sites and I-2-imidazoline receptors (I-2-IR) has been established in human brain on the basis of correlational studies of radiolabelled binding sites. Because both MAO-B and Il-IR densities increase with aging, the age at death could be partially involved in the observed correlations. The evaluation of two independent but similar datasets demonstrated that the linear correlation between MAO-B and la-IR densities dropped from 0.70 (P = 0.02) and 0.41 (P = 0.14) in the crude analyses to the negligible values of 0.07 (P = 0.84) and 0.09 (P = 0.75) when the age at death was controlled for in the statistical analyses. The results lead to conclude, contrary to former interpretations, that there is not any statistical association linking both MAO-B catalytic unit sites and Ip-IR densities in the human brain. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:135 / 138
页数:4
相关论文
共 20 条
[1]   THE EFFECTS OF PHENELZINE AND OTHER MONOAMINE-OXIDASE INHIBITOR ANTIDEPRESSANTS ON BRAIN AND LIVER I-2 IMIDAZOLINE-PREFERRING RECEPTORS [J].
ALEMANY, R ;
OLMOS, G ;
GARCIASEVILLA, JA .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (04) :837-845
[2]  
CARPENE C, 1995, J PHARMACOL EXP THER, V272, P681
[3]   'Seeing through a glass darkly': casting light on imidazoline 'I' sites [J].
Eglen, RM ;
Hudson, AL ;
Kendall, DA ;
Nutt, DJ ;
Morgan, NG ;
Wilson, VG ;
Dillon, MP .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (09) :381-390
[4]   MONOAMINE OXIDASE-B IN ASTROCYTES [J].
EKBLOM, J ;
JOSSAN, SS ;
BERGSTROM, M ;
ORELAND, L ;
WALUM, E ;
AQUILONIUS, SM .
GLIA, 1993, 8 (02) :122-132
[5]   Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: Relationship with non-adrenoceptor [H-3]-idazoxan binding sites [J].
Escriba, PV ;
Alemany, R ;
Sastre, M ;
Olmos, G ;
GarciaSevilla, JA .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (08) :2029-2036
[6]  
Fisher L.D., 1993, BIOSTATISTICS METHOD
[7]   Imidazoline receptor proteins in brains of patients with Alzheimer's disease [J].
García-Sevilla, JA ;
Escribá, PV ;
Walzer, C ;
Bouras, C ;
Guimón, J .
NEUROSCIENCE LETTERS, 1998, 247 (2-3) :95-98
[8]   AGE-DEPENDENT INCREASES OF IMMUNOREACTIVE IMIDAZOLINE RECEPTORS IN THE HUMAN BRAIN - POSSIBLE ASSOCIATION OF A 29/30-KDA PROTEIN WITH THE I-2-IMIDAZOLINE RECEPTOR IDENTIFIED BY [H-3] IDAZOXAN [J].
GARCIASEVILLA, JA ;
SASTRE, M ;
ESCRIBA, PV .
NEUROSCIENCE LETTERS, 1995, 184 (02) :133-136
[9]  
Maeztu AI, 1997, ALCOHOL CLIN EXP RES, V21, P1479
[10]   Increased density of I-2-imidazoline receptors in human glioblastomas [J].
MartinGomez, JI ;
Ruiz, J ;
Callado, LF ;
Garibi, JM ;
Aguinaco, L ;
Barturen, F ;
Meana, JJ .
NEUROREPORT, 1996, 7 (08) :1393-1396